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Abstract
Background: HIV and Hepatitis C virus (HCV) infections are strongly related to injection drug use in the Republic
of Georgia. Little information is available about HIV and HCV status, sexual risk, support for their partner, and risk
for physical violence among the female partners of opioid-injecting men in the Republic of Georgia, many
of whom may not be using drugs, yet may be at high risk of being infected with HIV and HCV from their
drug-using partners.
Methods: In order to better understand the risks for females whose partners are injecting drugs, the present study
conducted an initial investigation of the non-substance-using female partners of 40 opioid-injecting men who were
participating in a clinical trial examining the feasibility and efficacy of a 22-week comprehensive intervention that
paired behavioral treatment with naltrexone. The 40 female partners were assessed at their male partners’
study intake.
Results: The female sample was 32.3 years old (SD=6.7), 37 (93%) were married, with 15.5 years of education. A
majority reported at least partial employment the majority of the time during the past 3 years, with only one
woman reported being unemployed most of the time during the past 3 years. They self-reported they were 3%
HIV-positive and 8% HCV-positive. Their HIV sex risk scores indicated a relatively low risk. However, only 4 (10%)
women reported using a condom most of the time while having sex and 15 (38%) report not having had sex
during the last 30 days. Experiences of interpersonal violence were common, with 42% reporting physical abuse by
their partner during the last year and 48% reporting feeling unsafe in their current relationship.
Conclusions: The alarmingly high rate of failure to use barrier protection methods, together with the high
percentage who did not know their HIV and HCV status, suggest that it may be beneficial to include
non-substance-using female partners in prevention programs along with their partners to reduce the risk of HIV
and HCV spreading from the population of injection-drug–using males into the general population. [This secondary
analysis study was funded by an international supplement to the parent randomized clinical trial “Treating the
Partners of Drug Using Pregnant Women: Stage II (HOPE)”. ClinicalTrials.gov Identifier: NCT00496990.]
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Background
In the Republic of Georgia there has been a swift and
consistent rise in the number of individuals registered as
HIV-positive since 1994 [1]. As of September, 2012 there
were a cumulative 3,400 HIV-positive cases registered
with the National AIDS Centre, with the overall number
of people living with HIV/AIDS estimated to be more
than 4,000 [2]. Among injection-drug-using adults, the
HIV prevalence rate was estimated to be about 1½% in
2010 [3]. This rate is about 2½ times higher than the
average prevalence in Europe [4]. The prevalence of
hepatitis C (HCV) is estimated to be in the range of
50-70% [5]. This HCV epidemic in Georgia is a major
public health concern, and is being driven by injection-
drug-using adults. However, other non-drug-using
groups have been affected as well, with HCV prevalence
in the general population estimated to be 6.7% [6]. Al-
though the overall prevalence of HIV in Georgia is low
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compared to other former Soviet Union states, the dra-
matic increase in HIV and AIDS remains a cause for ser-
ious concern and there is an urgent need to address the
spread of HIV/AIDS. Injection drug use has a central
role in the increased HIV prevalence in the region [7].
Prevalence of injection drug use is estimated to be about
1½% in the adult population. Popular injection drugs in-
clude heroin and the buprenorphine-mono product, and
more recently home-produced amphetamine type stimu-
lants and opioids. The vast majority (98%) of known
opioid injectors in Georgia are men. About 60% of all
HIV-infected males in Georgia use injection drugs [1].
Many opioid-injecting men are married to illicit-drug-
free women, and have never been in drug treatment [8].
While partners and wives of opioid-injecting men in
Georgia are exposed to several risk factors resulting
from their male partner’s substance addiction, little if
any research has been conducted regarding these
women. One of the health risks illicit-drug-free women
involved with opioid-injecting men face is having their
partner infect them with HIV or HCV. Injection drug
use is the primary cause of the HIV and HCV epidemics
in adult males in the region. Among the majority of men
(67.7%) with HIV in the Southern Caucasus region, HIV
infection is attributed to injection drug use. In contrast,
the majority of women (93.6%) with HIV have been
infected through heterosexual contact with an opioid-
injecting male partner [7,9,10]. In Georgia more than
70% of the HIV-positive women infected with HIV
through heterosexual contact were partners of injection-
drug-using males [11].
In any culture, substance use is often accompanied by
intimate partner violence [12,13]. In Georgia, this can be
deeply influenced by social norms and traditions, and
cultural environment that stipulates the asymmetry in
gender roles and the marked difference in the level of
women’s freedom and independence [14]. In the general
population, 9.1 % of women who have ever been married
or had an intimate partner have experienced violence
from their husbands/partners, and 3.9% of women
reported having experienced sexual violence. On the
other hand, 78.3% of women think that family problems
should only be discussed within a family, and 52.1% of
women think that if a man mistreats his wife, others out-
side the family should not intervene [15]. In addition, it
has been suggested that the recent economic develop-
ment weakened men’s position and, against the norma-
tive stereotypes, facilitated women’s rising dominance
through increased employment opportunities. “Having
lost their traditional position in the family (together with
their self-esteem) men need to reaffirm their rights and
they often do it through drinking and showing their
physical power while being drunk” [15]. Prevalence of
male physical aggression towards female partners is
approximately six times higher among couples where
the man has alcohol or drug problems compared to cou-
ples where the man does not have substance abuse pro-
blems [16]. Opioids may not typically lead to more
aggression [12], but multi-substance use is common
among individuals that use opioids [17] and the majority
of injecting-drug-using adults in Georgia seem to use
poly-substances [5,18]. This research would strongly
suggest that Georgian women in relationships with
opioid-injecting men are likely to be at increased risk of
experiencing intimate partner violence.
The present secondary analysis study has two primary
aims. The first aim was to examine HIV and HCV preva-
lence among the illicit-drug-free female partners of
opioid-injecting men in the Republic of Georgia. The
second aim was to examine the prevalence of interper-
sonal violence and feeling unsafe in their current rela-
tionship among these women.
Methods
Setting
The study was conducted at the Alternative Georgia
(http://www.altgeorgia.ge/?lang=2) field site. This inde-
pendent nonprofit research institution is located in a
central district of Tbilisi, Georgia.
Participants
To describe the participants in the present study, we
first describe their opioid-injecting- male partners, who
were the primary focus of the parent study [2]. Male
participants were recruited by flyers, word-of mouth,
and advertisements given to harm reduction programs
and hospital staff. Face-to-face screening interviews on
the research site were conducted. A total of 74 men be-
tween May 2006 and January 2009 were screened. Of
these men, 19 failed to show for their initial intake ap-
pointment, while 55 were evaluated for eligibility on the
following criteria: 18 years or older, having a current
illicit-drug-free intimate female partner with whom they
had regular contact, lack of current suicidal ideation,
meeting DSM-IV criteria for current opioid dependence,
not meeting DSM-IV criteria for thought disorder and
free of cognitive impairment that prevent them from
completing the study [19,20]). Men who indicated
current physical abuse of their female partner to an ex-
tent that might be life threatening were excluded from
the study. Men who indicated no current physical abuse
towards their female partner, or physical abuse that
would not be deemed to cause serious physical harm,
were included in the study. Following successful admin-
istration of baseline screening instruments, 20 men were
randomized to behavioral treatment+naltrexone and 20
men to “usual care”. All 40 men were then asked to pro-
vide a blood sample to test for HIV and HCV. One of
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the men (3%) was HIV-positive, 22 (55%) were HIV
negative, 13 (33%) refused to provide blood for testing
and 4 (10%) dropped out of the study; 24 (60%) men
tested positive for HCV, 5 (13%) men tested negative, 7
(18%) refused to provide blood for testing, and 4 (10%)
then dropped out of the study [19].
After their opioid-injecting male partners had con-
sented to participate in the study and had been screened
the female partners were informed about the study by
their male partners. The female partners were invited to
visit the research site and sign a written informed con-
sent. All 40 female partners visited and consented to
participate in the study, and all self-reported no prior
history of illicit drug use as part of a baseline intake that
also collected demographic data. All female participants
received cash equivalent of $18 US for their interview.
The behavioral treatment plus naltrexone intervention
for the male participants utilized counseling sessions
with Motivational Interviewing for both the male partici-
pant and the couple, monetary rewards for drug abstin-
ence, and detoxification followed by naltrexone
treatment. Male participants in the usual care treatment
arm were provided once-a-week individualized drug
education sessions together with referrals to detoxifica-
tion and aftercare, at their request.
The project was approved by the Institutional Review
Boards of the Georgian HIV/AIDS Patients Support
Foundation and Johns Hopkins University.
Measures
All measures were translated into Georgian, and then in-
dependently back-translated into English to determine
accuracy of the initial translation. Questions were exam-
ined for cultural appropriateness and were adjusted to
reflect the Georgian local socio-cultural context, such as
specifics of local education system, income rates, illicit
drugs availability, and so forth. Any final adjustments to
each measure were undertaken following examination of
the original scale and the back-translation.
The Baltimore risk assessment battery (BRAB)
To measure HIV drug-risk, a modified version of the
HIV Risk Assessment Battery (RAB) was used, the Balti-
more Risk Assessment Battery [21,22]. The BRAB sex-
risk score included 9 questions: (1) sexual orientation
[score: 0 (Heterosexual) or 1 (bisexual)], (2) number of
male partners, (3) number of female partners, (4) fre-
quency of exchanging sex for drugs, (5) frequency of ex-
changing drugs for sex, (6) frequency of exchanging sex
for money, (7) consistency of condom use, (8) frequency
of exchanging money for sex, and (9) frequency of sex
with someone of known HIV/AIDS positive status.
Questions (2)-(9) used 4-point rating scales, scored 0–3.
Possible scores range from 0 to 25, inclusive, with higher
scores indicating greater HIV sex-risk behavior.
Partner support questionnaire (PSQ)
The PSQ, based on the self-report Norbeck Social Sup-
port Questionnaire [23], is a 16-item questionnaire, with
each item scored on a 5-point scale, from 0 = “never” to
4 = “very often”. It asks the respondent to rate herself
on various aspects of her support for her partner in
reaching and maintaining drug abstinence (e.g., “Do you
compliment your partner on not using heroin”; “Do you
help your partner to think of things to do other than
using heroin”). Possible scores ranges from 0 to 64, in-
clusive, with higher scores indicating greater support.
Two additional binary items were added to the end of
the PSQ: “Have you been hit, kicked, punched, or other-
wise hurt by your partner within the past year? (past
month for follow-up assessments)” and “Do you feel safe
in your current relationship?’ which were not scored as
part of the PSQ. These two items were examined separ-
ately in order to assess if the women had experienced
interpersonal violence during the year prior to the inter-
view and whether they felt safe in their current
relationships.
Statistical analyses
Descriptive information on background characteristics,
HIV and HCV status, sex risk, physical abuse, and feel-
ing unsafe in the current relationship is presented in
terms of frequencies and percentages or means and
standard deviations.
Results
Participant characteristics
On average, the women, all of whom were Caucasian,
the majority of whom being native Georgian (88%), with
the remaining 12% nationals of neighboring countries
(Russia, Armenia, and Azerbaijan), were 32.3 years old,
37 (93%) were married, with an average 15.5 years of
education (Table 1). A majority reported at least partial
employment the majority of the time during the past 3
years. Only one woman reported being unemployed
most of the time during the past 3 years. The most com-
mon employment occupation was business manager
(33%) followed by clerical/sales and semiskilled, each
reported by 13%.
Prevalence of HIV and HCV
HIV and HCV status of the women participants was deter-
mined by self-report. Positive HIV status was reported by
one woman. She indicated that she was infected with HIV
following sexual contact with her husband who got
infected in prison due to sharing syringes. Negative HIV
status was reported by 20 women and 15 reported they
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were unaware of their HIV status (Table 2). Positive HCV
status was reported by 3 women, 24 reported negative
HCV status, and 9 women reported they were unaware of
their HCV status. Four female participants dropped out of
the prior to the self-reported assessment of their HIV and
HCV status. These 4 women participants were the
partners of the men who had refused to provide a blood
sample for testing and dropped out of the study.
Given the relatively large percentage of the sample un-
aware of their HIV and HCV status, answers to these
two questions were examined for their male partners. Of
the 15 women who did not know their HIV status, 13 of
their male partners had refused to provide blood for
testing, while of the 9 women who were unaware of their
HCV status, 7 of their male partners refused to undergo
HCV testing.
Sex risk
Because of the lack of variability in responding to the
items on this scale (see following), no internal
consistency reliability for the BRAB HIV sex risk scale is
reported.
The BRAB HIV sex risk score (Table 3) does indicate a
relatively low risk for the women. All women reported
themselves to be exclusively heterosexual, and no
women reported she had exchanged sex for drugs or
money, or exchanged drugs or money for sex. However,
only 4 (10%) women reported using a condom most of
the time while having sex and 15 (38%) report not hav-
ing had sex during the last 30 days. Of these 15 women,
7 (47%) of their male partners indicated that they had
not had sex in the last 30 days, with 2 of the remaining
8 men indicating they used condoms “all of the time”, 1
“most of the time”, and 5 “some of the time”. One
woman reported having HIV-positive male partner (one
of the male participants in the parent study was HIV-
positive), and indicated that she had used condoms
“most of the time” in the last 30 days. Twenty women
Table 1 Background Characteristics for illicit-drug-free
female partners of opioid-injecting men in the Republic
of Georgia (N=40)
M (SD) f (%)
Age 32.3 (6.7)
Education (years) 15.5 (2.2)
Married 37 (93%)
Usual employment last 3 years:
Full-time student (unemployed) 3 (8%)
Housewife 12 (30%)
Unemployed (seeking job) 1 (3%)
Part time (<35 hours per week) 13 (33%)
Full time 10 (25%)
Irregular hours 1 (3%)
Usual or last occupation:
Higher executives 1 (3%)
Business managers 13 (33%)
Administrative Personnel 4 (10%)
Clerical and Sales 5 (13%)
Skilled Manual 2 (5%)
Semiskilled 5 (13%)
Unskilled 1 (3%)
Never worked 9 (23%)
Currently employed 19 (48%)
Table 2 HIV and Hepatitis C status among illicit-drug-free
female partners of opioid-injecting men in the Republic
of Georgia (N=40)
f (%)
HIV status
Positive 1 (3)
Negative 20 (50)
Unknown 15 (38)
Drop-out 4 (10)
Hepatitis C status
Positive 3 (8)
Negative 24 (60)
Unknown 9 (23)
Drop-out 4 (10)
Table 3 Sex-risk, partner support, and physical abuse
and safety among illicit-drug-free female partners of
opioid-injecting men in the Republic of Georgia (N=40)
M (SD) f (%)
Baltimore Risk Assessment Battery (BRAB) †
Total sex risk scale score 3.6 (1.7)
How often used a condom while having
sex the past 30 days
Have not had sex the last 30 days 15 (38)
Some of the time 21 (53)
Most of the time 4 (10)
How worried about getting HIV/AIDS ‡
Not at all 20 (51)
Slightly/moderately 12 (31)
Considerably/extremely 7 (18)
Partner support questionnaire (PSQ) * 41.0 (5.9)
Hit/kicked/punched by partner in the last year 17 (42)
†Sex Risk scale has a possible range of 0–25, inclusive.
‡One participant was missing data for this question.
*PSQ had a possible range of 0–64, inclusive.
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(51%) were not at all worried and 7 (18%) were consider-
ably or extremely concerned about getting HIV/AIDS.
Partner support
The PSQ had an internal consistency reliability α = .78
in this sample, indicating that the scale score could be
considered a reliable measure of partner support.
The women generally believed they often provided
support (see Table 3), with scores ranging from 22 to 50,
inclusive. Assuming the theoretical midpoint of the scale
would be 32 (an average item score of 2 = “sometimes”),
only 3 women provided support that might be seen as
less than adequate.
Physical abuse and safety
Physical abuse by their partner within the last year was
reported by 42% of the women, and 48% said they felt
unsafe in their current relationship.
Discussion
Female partners of injection-drug-using men in the Re-
public of Georgia are at high risk for contracting HIV
and HCV [9]. This is the first study that describes the
prevalence of HIV and HCV among this recently identi-
fied high-risk group of illicit-drug-free female partners
of opioid-injecting men in the Republic of Georgia, al-
most all of whom were married.
When asked about their HIV status only one woman
reported that she was HIV-positive, half said they were
HIV negative, and more than one third stated they were
never tested. A small number of women reported being
infected with HCV, almost two-thirds said they were
HCV-negative, and close to one in four stated they were
unaware of their status. It has been reported that stigma
against and fear of discrimination has led many people
in Georgia to conceal a positive HIV status [24]. This
situation might be the case for some of the women in
the present study as well, and may extend to revealing
HCV status. Kirtadze et al. [25] examined the attitudes
and beliefs of 34 health service providers in Georgia who
had contact with injection-drug-using women. These
providers indicated less tolerance towards such women,
believing they were failures as a good mother, wife, or
child. The authors concluded that drug-using women in
Georgian culture were “twice stigmatized” – as failed
mothers/wives/daughters, and as less acceptable than
men, even drug-using men.
In addition, the parent study records suggest that male
participants refused HIV testing due to the fear of being
diagnosed positive (e.g., “It is better if I do not know if I
am infected”), and refused HCV testing due to lack of
available treatment options (e.g., “even if I am positive
there is no treatment that I can afford”). This might well
explain low motivation of participants, both, males and
females, to know their health status.
Half the women reported not being worried about
contracting HIV/AIDS and less than one in five reported
being considerably or extremely worried about being
infected with HIV/AIDS. The low prevalence of concern
is surprising since a majority of women with HIV in
Georgia have been infected from a partner who injects
drugs [9]. The limited understanding of and attitude to-
wards HIV/AIDS in Georgia suggests that there may be
a serious lack of available information about risk factors
for HIV infection [6]. Alternately, there may be a taboo
among Georgian women to express worry about con-
tracting HIV/HCV, due to the heavy social stigma asso-
ciated with these infections. Moreover, the fear of being
arrested and a lack of trust in health care providers con-
tribute to the fact that only about 5% of injection-drug-
using adults in Georgia are tested for HIV on a regular
basis [7]. Therefore, it may be the case that the preva-
lence of HIV is notably higher among injection-drug-
using adults than what has been estimated.
Moreover, despite a low average sex risk score, only 1
in 10 women reported that her partner used a condom
most of the time. The women may be influenced by the
widespread belief among Georgian women that if they
are not injecting drugs or are sex workers, they are not
at risk of HIV or HCV infection [7]. Safe sex would be a
protective factor against HIV and HCV for the women.
However, other studies have also found that sexually ac-
tive women in Georgia rarely use or discuss using con-
doms with their partners [24]. More than a third of the
women reported not having had sex during the last 30
days. These results merit further research to determine
the extent that low rates of sexual activity are related to
the slow spread of HIV and HCV among women in the
Republic of Georgia. Previous research has revealed a
low level of knowledge of HIV risk factors and high
prevalence of unsafe sex among the general population
in Georgia [6]. Inadequate knowledge of HIV risk factors
and methods for HIV risk reduction seem to be a wide-
spread problem in Georgia [6]. Results of the present
study would suggest that unsafe sex frequently occurs in
an extremely high-risk population, non-drug-using fe-
male partners of injection-drug-using men.
High-risk injection practices are common in the Re-
public of Georgia. Previous research reported that in
some subgroups more than four out of five opioid-
injecting drug-using men in Georgia are sharing needles
with others [26,27]. Thus, even if the opioid-injecting
male partners of illicit-drug-free females are not having
sex with other women or men, the male partner remains
at high risk of getting infected with HIV and HCV and
passing these infections to his female partner through
sexual contact.
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The women generally perceived themselves as sup-
portive of their partners’ efforts to reach and maintain
abstinence.
Seventeen women (43%) had experienced physical
abuse by their partner within the last year prior to the
interview and close to half reported feeling unsafe in
their current relationship. In a study including more
than 1,000 women in the general population in Georgia,
6% reported experiencing physical violence and 11% sex-
ual violence during the last five years. This study mea-
sured all physical and sexual violence, not just violence
by partner [28]. Another study including close to 8,000
women in Georgia reported that 2% had experienced
physical abuse and 3% sexual abuse by a partner during
the last 12 months [27]. Females in a relationship with
an opioid-injection drug-using male partner seem to be
at increased risk of experiencing interpersonal violence
compared to the general population of women in Geor-
gia. Another health risk is that the drug-injecting man
will initiate his partner into drug use. Women com-
monly start using drugs because of their partner [29,30].
Preventing female partners of opioid-injecting men from
initiating drug use is a critically important goal. Includ-
ing these women in their partner’s treatment program
might enable them to improve their relationship with
their partner, learn how to resist the use of illicit drugs,
and better support their partner in his rehabilitation.
Study limitations
First, the sample size of the present study was relatively
small. Therefore, the findings need to be interpreted
with restraint. Second, selection bias that attracted moti-
vated males in a stable relationship with an interest in
treatment might have operated to yield a sample of men
who are more likely to engage in safe sex practices. It is
difficult to determine the extent to which this statement
might be true, given the high non-response rate regard-
ing HIV and HCV infection for the male as well as the
female participants. Selection bias may have been further
compounded by attrition. Thus, the small sample size
and the impact of both selection bias and attrition may
have adversely impacted the ability to determine precise
estimates of HIV and HCV in the population of non-
substance-using female partners of injection-drug-using
men. Third, a relatively large number of men who
expressed an interest in participation in the parent study
failed to enter the study: 19/74 (26%) failed to show up
for their intake appointment, and 15/74 (20%) were
determined to be ineligible. Because information on the
women in the present study is gathered from the female
partners of the male participants, such a relatively
high rate of participant loss potentially limits the
generalizability of the findings. However, the rate of
non-participation is not unexpected, because the parent
study focused on attracting non-treatment-seeking men
into treatment. Fourth, stigma and the attendant fear of
disclosure may have operated to restrict the range of
responding and increase the chances of socially desirable
responding, also limiting our ability to generalize our
findings. Fifth, HIV and HCV status was based on self-
report measures. Thus, the reliability of such data
depends on truthful answers from respondents. Sixth,
there was a relatively large amount of missing data on
for the questions regarding HIV and HCV status, be-
cause the women failed to answer these questions. Being
either HIV-positive or HCV-positive is associated with
considerable stigma in Georgia, and fear of
stigmatization may have influenced some respondents to
refuse to answer these questions – or, potentially to an-
swer in socially desirable ways. Finally, information on
sexual violence or abuse independent of physical vio-
lence was not collected.
Strengths of the study
Research on non-opioid-injecting female partners of
opioid-injecting men is scarce, both in the Republic of
Georgia and elsewhere [31]. Information about HIV sta-
tus, HCV status, sex risk behavior, concern about getting
HIV and interpersonal violence may prove invaluable for
designing HIV interventions for injection-drug-using
men and their female partners. We can envision that
public health efforts should be focused in two directions.
First, efforts need to be made to provide additional
information to potentially sexually active Georgian
women – particularly female partners of injection-drug-
using men – that barrier protection methods are the
best protection against HIV and and HCV infection. Sec-
ond, providing couples therapy in some form, even if
only for 2–3 sessions, may allow for direct outreach and
education of both members of the couple on the risks of
HIV and HCV infection.
Conclusions
In settings where prevalence of HIV/AIDS is low, the
epidemic is mostly concentrated within specific groups,
as is the case of Georgia, in injecting-drug-using adults.
Preventive interventions should target populations at
risk for HIV transmission. Such targeted evidence-based
interventions have maximal impact in terms of both pre-
venting the spread of infection and allowing for the most
efficient allocation of limited financial resources. A high
proportion of the women in the present study had never
been tested for HIV and HCV, and reported no motiv-
ation to do so when offered. This, along with the low
reporting of condom use, strongly indicate the need for
targeted education efforts that would provide informa-
tion about disease development and treatment options,
and would encourage this population to seek appropriate
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counseling and testing. Prevention programs should
educate both the injection-drug-using male and his fe-
male partner in the risks of HIV and HCV transmission
from unprotected sex, and thereby to reduce the risk of
HIV and HCV transmission from the population of
injection-drug–using individuals into the general popu-
lation. These women are also at alarming risk compared
to the general population of women for experiencing
interpersonal violence.
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